0111 Envudeucitinib, an allosteric TYK2 inhibitor, inhibits TYK2-relevant biomarkers in skin using spatial transcriptomics
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S20
DOI: 10.1016/j.jid.2026.06.142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von N. Narayan und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Narayan, N., Hoffman, J., Langrish, C., Corpuz, P., Vlahakis, N., & Tilley, M. (2026). 0111 Envudeucitinib, an allosteric TYK2 inhibitor, inhibits TYK2-relevant biomarkers in skin using spatial transcriptomics. Journal of Investigative Dermatology, 146(8), S20. https://doi.org/10.1016/j.jid.2026.06.142
Vancouver
Narayan N, Hoffman J, Langrish C, Corpuz P, Vlahakis N, Tilley M. 0111 Envudeucitinib, an allosteric TYK2 inhibitor, inhibits TYK2-relevant biomarkers in skin using spatial transcriptomics. Journal of Investigative Dermatology. 2026;146(8):S20. doi:10.1016/j.jid.2026.06.142
BibTeX
@article{Narayan2026,
author = {Narayan, N. and Hoffman, J. and Langrish, C.L. and Corpuz, P.R. and Vlahakis, N.E. and Tilley, M.K.},
title = {0111 Envudeucitinib, an allosteric TYK2 inhibitor, inhibits TYK2-relevant biomarkers in skin using spatial transcriptomics},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S20},
doi = {10.1016/j.jid.2026.06.142}
}
EUVIMED